Neogen Announced as an Official Sponsor of US Equestrian
Neogen (NASDAQ: NEOG) has announced a sponsorship agreement with US Equestrian to enhance equine care solutions. The partnership will focus on developing educational materials about equine botulism, a deadly neuromuscular disease affecting horses. Neogen, known for producing BotVax® B, the only USDA-approved vaccine for botulism Type B in horses, will collaborate with US Equestrian to create resources on prevention techniques and treatment protocols.
The initiative aims to raise awareness about the silent killer that can be found in hay, feed, and soil. US Equestrian members will have access to these free resources in fall 2024, coinciding with vaccination season. This partnership underscores Neogen's 30-year commitment to the equestrian community and aligns with US Equestrian's goal of providing quality resources for horse care.
Neogen (NASDAQ: NEOG) ha annunciato un accordo di sponsorizzazione con US Equestrian per migliorare le soluzioni di cura equina. La partnership si concentrerà sullo sviluppo di materiali educativi riguardo al botulismo equino, una malattia neuromuscolare mortale che colpisce i cavalli. Neogen, noto per la produzione di BotVax® B, l'unico vaccino approvato dal USDA per il botulismo di tipo B nei cavalli, collaborerà con US Equestrian per creare risorse sulle tecniche di prevenzione e i protocolli di trattamento.
L'iniziativa mira a sensibilizzare riguardo a questo killer silenzioso che può trovarsi nel fieno, nei mangimi e nel suolo. I membri di US Equestrian avranno accesso a queste risorse gratuite nell'autunno del 2024, in coincidenza con la stagione dei vaccini. Questa partnership sottolinea l'impegno di 30 anni di Neogen verso la comunità equina e si allinea con l'obiettivo di US Equestrian di fornire risorse di qualità per la cura dei cavalli.
Neogen (NASDAQ: NEOG) ha anunciado un acuerdo de patrocinio con US Equestrian para mejorar las soluciones de cuidado equino. La asociación se centrará en el desarrollo de materiales educativos sobre el botulismo equino, una enfermedad neuromuscular mortal que afecta a los caballos. Neogen, conocido por producir BotVax® B, la única vacuna aprobada por el USDA para el botulismo tipo B en caballos, colaborará con US Equestrian para crear recursos sobre técnicas de prevención y protocolos de tratamiento.
La iniciativa tiene como objetivo aumentar la conciencia sobre este asesino silencioso que puede encontrarse en el heno, los piensos y el suelo. Los miembros de US Equestrian tendrán acceso a estos recursos gratuitos en otoño de 2024, coincidiendo con la temporada de vacunación. Esta asociación subraya el compromiso de 30 años de Neogen con la comunidad ecuestre y se alinea con el objetivo de US Equestrian de proporcionar recursos de calidad para el cuidado del caballo.
Neogen (NASDAQ: NEOG)은 말 관리 솔루션을 향상시키기 위해 US Equestrian과 후원 계약을 체결했다고 발표했습니다. 이 파트너십은 말에게 치명적인 신경근 질환인 말 보툴리즘에 대한 교육 자료 개발에 중점을 둘 것입니다. 보툴리즘 유형 B에 대한 USDA 승인 백신인 BotVax® B를 생산하는 것으로 알려진 Neogen은 예방 기술 및 치료 프로토콜에 대한 자료를 만들기 위해 US Equestrian과 협력할 것입니다.
이 이니셔티브는 건초, 사료 및 토양에서 발견될 수 있는 이 침묵의 살인자에 대한 인식을 높이는 것을 목표로 합니다. US Equestrian 회원들은 2024년 가을에 이러한 무료 자원에 접근할 수 있으며, 이는 백신 접종 시즌과 일치합니다. 이 파트너십은 Neogen의 30년간의 조랑말 커뮤니티에 대한 헌신을 강조하며, US Equestrian의 고품질 말 관리 자원을 제공하려는 목표와 일치합니다.
Neogen (NASDAQ: NEOG) a annoncé un accord de parrainage avec US Equestrian pour améliorer les solutions de soins équins. Le partenariat se concentrera sur le développement de matériaux éducatifs concernant le botulisme équin, une maladie neuromusculaire mortelle affectant les chevaux. Neogen, connu pour produire le BotVax® B, le seul vaccin approuvé par le USDA contre le botulisme de type B chez les chevaux, collaborera avec US Equestrian pour créer des ressources sur les techniques de prévention et les protocoles de traitement.
Cette initiative vise à sensibiliser à ce tueur silencieux que l'on trouve dans le foin, les aliments et le sol. Les membres d'US Equestrian auront accès à ces ressources gratuites à l'automne 2024, coïncidant avec la saison des vaccinations. Ce partenariat souligne l'engagement de 30 ans de Neogen envers la communauté équestre et s'aligne avec l'objectif d'US Equestrian de fournir des ressources de qualité pour le soin des chevaux.
Neogen (NASDAQ: NEOG) hat eine Sponsoring-Vereinbarung mit US Equestrian angekündigt, um Lösungen für die Pferdepflege zu verbessern. Die Partnerschaft konzentriert sich auf die Entwicklung von Bildungsunterlagen über Pferdebotulismus, eine tödliche neuromuskuläre Erkrankung bei Pferden. Neogen, bekannt für die Herstellung von BotVax® B, dem einzigen vom USDA zugelassenen Impfstoff gegen Botulismus Typ B bei Pferden, wird mit US Equestrian zusammenarbeiten, um Ressourcen zu Präventionsmethoden und Behandlungsprotokollen zu erstellen.
Die Initiative zielt darauf ab, das Bewusstsein für diesen stillen Killer zu schärfen, der in Heu, Futter und Boden vorkommen kann. Die Mitglieder von US Equestrian werden im Herbst 2024 Zugang zu diesen kostenlosen Ressourcen haben, zeitgleich mit der Impfkampagne. Diese Partnerschaft unterstreicht das 30-jährige Engagement von Neogen für die Reitgemeinschaft und stimmt mit dem Ziel von US Equestrian überein, hochwertige Ressourcen für die Pferdepflege bereitzustellen.
- Partnership with US Equestrian enhances Neogen's market presence in the equine health sector
- Opportunity to increase awareness and potentially boost sales of BotVax® B vaccine
- Access to US Equestrian's member base for educational outreach and marketing
- None.
Neogen and US Equestrian will together develop member-accessible educational materials on best practices, prevention techniques, and recommended treatment protocols for cases of equine botulism, a progressive neuromuscular disease that leads to weakness and muscle paralysis in equines and is often fatal. This deadly neurotoxin, often referred to as a silent killer, can be found in hay, feed, and soil, posing a significant and often overlooked threat to horses.
An industry leader in the research and prevention of equine botulism, Neogen produces BotVax® B, the only USDA-approved vaccine for botulism Type B in horses.
"Education is a critical component to help horse owners understand and prevent this deadly disease," said Renee Hall, Head of Pet Health and Wellness for Neogen. "Horse owners, if they understand the threat of botulism, know that the culprit is not just round bales of hay. Botulism can be found in many forage types and cannot be seen or smelled. We all know that an ounce of prevention is worth a pound of cure."
"Neogen has been part of the equestrian community for more than 30 years and has focused efforts on providing quality horse health products, from wound care and vaccines to genetic testing and biosecurity solutions," said Bill Moroney, US Equestrian Chief Executive Officer. "Neogen's commitment to research on equine botulism is important and aligns with the goal of providing our members with quality resources and access to experts to help them care for their horses. We welcome Neogen as a sponsor of US Equestrian and look forward to working together."
US Equestrian members will have access to these free resources this fall, just in time for vaccination season.
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
Contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-announced-as-an-official-sponsor-of-us-equestrian-302227788.html
SOURCE Neogen Corporation
FAQ
What is the new partnership between Neogen (NEOG) and US Equestrian?
When will US Equestrian members have access to Neogen's (NEOG) equine botulism resources?
What product does Neogen (NEOG) produce for equine botulism prevention?
How long has Neogen (NEOG) been involved in the equestrian community?
